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The enormous impact of the so-called technology explosion
in cardiovascular medicine is well known. Figure 1 reminds
us that the cognitive aspects of our specialty have expanded
in concert with technology and that patients who we used to
see only in terms of black or white are now routinely
evaluated in terms of the broad spectrum between the
extremes. Our task as cardiovascular specialists is to locate
the appropriate diagnostic and therapeutic shade of gray for
each patient. My theme today is that cognitive issues are
more dominant in this process than we often realize. I hope
to illustrate this point by discussing two of our most com-
monly used technologies. coronary arteriography and stud-
ies of myocardial perfusion. as they relate to coronary artery
disease.
Figure 2 reminds us that patient care decisions in coro-
nary artery disease usually involve considerations of arterio-
graphic status, left ventricular function and the individual
clinical profile. The clinical profile, of course, includes a
number of pertinent variables. and perfusion studies are only
one of these. Let us begin. however. by considering coro-
nary arteriography.
Coronary Arteriography
Relations among coronary stenosis, resistance and flow,
Figures 3and 4 make two general points about the functional
implications of individual arteriographic lesions. The first
relates to the relation between stenosis resistance and flow.
As technically superior arteriography has become routine,
engineers and cardiologists have developed information that
allows us to think about coronary stenoses much as we have
traditionally thought about valvular aortic stenosis. As with
aortic stenosis, the pressure gradient across a coronary
stenosis increases with flow in a nonlinear fashion. a phe-
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nomenon called flow separation. When the pressure gradient
across the stenosis is plotted against flow. the relation is
therefore curvilinear. Imagine that the relation shown in
Figure 3 represents a 70% diameter stenosis associated with
effort-induced angina. Stenosis resistance can be expressed
as the tangent to the relation at any given level of flow. As
flow increases with effort. stenosis resistance also increases.
as reflected by the steeper slope of the tangent at the point of
increased demand versus the basal tangent. Thus, the func-
tional severity of even a rigid stenosis increases with effort,
and the symptomatic implications of any stenotic lesion
depend in part on the degree of activity a patient is likely to
achieve.
Functional importance of small differences in degree of
stenosis. In Figure 4 (left). the pressure gradient across the
stenosis is again plotted against coronary flow, with relations
shown for 30%. 50%, 80% and 90% as well as 70% diameter
stenoses. The tangents to these relations reflect stenosis
resistances at a given level of flow. In Figure 4 (right),
individual values of stenosis resistance are plotted against
degree of stenosis. Resistance increases relatively slowly
below 70% diameter narrowing. but then almost doubles
between 70% and 80% and doubles again between 80% and
90%. Even with technically excellent arteriograms. I think
that few of us would want to bet the house. so to speak. on
our ability to distinguish between stenoses in this range. It is
not surprising. therefore, that patients with apparently sim-
ilar lesions on arteriography can vary greatly in their clinical
presentation. The issues raised by Figure 4 concern more
than differences in arteriographic interpretation. however.
and we need to consider next factors that can change the
caliber of a stenosis from moment to moment.
Dynamic changes in degree of stenosis. We all recognize
that many atherosclerotic coronary lesions are eccentric.
with portions of the vessel wall that remain susceptible to
constrictor or dilator effects of vascular smooth muscle. One
important example of vasodilation was provided by the
careful studies of Brown et al. (I) in the early 1980s. With
use of quantitative arteriographic measurements of the
cross-sectional area of the lumen of human coronary steno-
ses. these investigators demonstrated that luminal area in-
creases systematically in response to intracoronary or sub-
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Figure 1. The "technology explosion" exposes the diagnostic
shades of gray.
lingual nitroglycerin and that stenosis vasodilation plays an
important role in the clinically beneficial effects of nitroglyc-
enn.
On the other side of the coin, a substantial body of
evidence now indicates that dynamic reductions in the
caliber of a stenotic lumen often playa crucial role in acute
ischemic syndromes. The list of possible vasoconstrictor
agents includes serotonin, thromboxane Az' histamine, en-
dothelin and platelet-related factors, among others. A small
thrombus can also narrow a stenotic lumen crucially and
play an important role in at least some acute ischemic
syndromes. As a thrombus is being formed, platelet activa-
tion serves as an amplifying factor for the release of vaso-
constrictor substances and a vicious cycle of increasing
luminal compromise is easily visualized. Paradoxic vasocon-
strictor responses are also possible. Normal endothelium
produces a dilator substance, endothelium-derived relaxing
factor, which is importantly involved in normal flow regula-
tion and which mediates the vasodilation normally occurring
when acetylcholine is injected into a coronary artery. When
endothelium is damaged, however, the normal dilator re-
sponse to acetylcholine can be reversed.
A study of Ludmer et aI. (2) illustrates this latter point.
When acetylcholine was injected into a normal coronary
artery, the epicardial portion of the artery dilated to a
modest but statistically significant degree. The artery also
Figure 3. Flow-related changes in functional severity of a coronary
stenosis (see text). t DEMAND = i,:!creased demand; LiP =
pressure gradient across the stenosis; Q = coronary flow; R =
stenosis resistance.
showed the usual dilator response to intracoronary nitro-
glycerin. In patients with coronary disease, acetylcholine
constricted rather than dilated the coronary artery, produc-
ing as much as a 75% reduction in diameter in the stenotic
segment itself and a 50% reduction in diameter immediately
proximal to the stenotic segment. This paradoxic constrictor
response to acetylcholine occurred in the presence of a
retained normal dilator response to nitroglycerin.
Interpretation of coronary arteriographic images: role of
quantitative arteriography. While considering cognitive is-
sues relating to the interpretation of arteriographic images,
we should also discuss the conventions used to describe
individual lesions. Percent diameter stenosis, the traditional
and still most commonly used standard, is of course mea-
sured as the maximal percent luminal narrowing in any single
arteriographic view and is obtained by comparing luminal
Figure 4. Functional importance of small differences in degree of
stenosis (see text). Abbreviations as in Figure 3.
Figure 2. Factors influencing patient care decisions in coronary
disease. LV = left ventricular. 90%
R 90%
% STENOSIS
FLOW (0)
CLINICAL PROFILE
(e.g., Perfusion Studies)
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Figure 5. Schematic representation of atherosclerotic coronary ar-
tery remodeling. Left. Normal coronary artery. Right. Sclerotic
coronary artery. I.E.L. = internal elastic lamina (thin solid line).
(Adapted from data of Stiel et al. [3].)
is attenuated by an increase in overall arterial diameter.
When we look at point B in the diseased artery, we see that
atherosclerotic enlargement is accentuated at points of clin-
ically recognizable stenosis. This local increase in degree of
enlargement can be expressed in terms of the ratio of the
areas contained within the internal elastic membrane at
points Band A. In the Hamburg series of patients (3), this
ratio averaged 1.79 in diseased arteries, as opposed to 0.93 in
nondiseased normally tapering arteries. Because the remod-
eling process is just beginning to be considered by cardiolo-
gists as well as pathologists. its implications for routine
arteriographic measurements are not yet clear. Note, how-
ever. that the percent luminal narrowing that would be
calculated on routine arteriography depends on the relative
luminal diameters at points A and B in the atherosclerotic
artery. Each diameter is the end result of a process involving
both atherosclerotic proliferation and overall arterial en-
largement. The degrees of proliferation and enlargement at
the two points differ substantially. however. Factors underly-
ing these local differences in degree of proliferation and en-
largement have an important effect on arteriographic measure-
ments of percent stenosis and need to be understood more
fully. The issues raised by Figure 5 may also affect arterio-
graphic studies of lesion progression or regression. or both.
Clinical implications: cognitive issues in interpretation.
Coronary arteriography routinely provides technically excel-
lent views of arterial luminal configuration. The presence or
absence of disease. the location and extent of disease and the
amount of myocardium at risk are reliably defined. The
exclusion of disease often has long-term cost-effectiveness
as well as clinical value. Arteriography defines the anatomic
possibilities for revascularization when clinically appropri-
ate. When sequential arteriographic studies are available,
progression or regression, or both, of luminal abnormalities
can also be examined. Prognostic information can be derived
Area within I.E.L.: S
B/ = 1.79 + 0.08
A (n=49)
s
- 10-20 mm,
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s/ = 0.93 + 0.05 (SD)
A (n=30)
diameter at the point of maximal narrowing to luminal
diameter in an adjacent portion of the same artery.
I also referred earlier to quantitative arteriography. In
this approach. cross-sectional area at the point of maximal
narrowing is calculated in absolute values, that is, in square
millimeters, with use of orthogonal views and the assump-
tion of an elliptic luminal shape. The advantage of expressing
luminal area in absolute rather than relative terms is that the
arteriographer avoids using the lumen adjacent to the steno-
sis (which is itself involved in the atherosclerotic process) as
a reference in the calculation of percent stenosis. For
example, an absolute luminal area that might represent an
80% narrowing in an otherwise normal artery could appear
as only a 40% stenosis in an artery with a diffusely thickened
wall if the overall vessel diameter were unchanged.
Quantitative arteriography has unquestioned value in
sequential assessments of an individual lesion, for example,
before and after nitroglycerin administration. Quantitative
arteriography does have an important limitation for routine
diagnostic use, however, in that it is difficult to judge
whether any specific absolute value of luminal area is normal
or abnormal. Arterial dimensions. including luminal cross-
sectional area, normally decrease progressively as one pro-
ceeds proximally to distally, from base to apex of the
ventricle. Dimensions also vary from patient to patient
depending on the pattern of coronary artery branching,
gender, body size and presence or absence of ventricular
hypertrophy. Because of the difficulty in determining
whether an absolute value of luminal area is normal or
abnormal, some arteriographers have switched to reporting
relative rather than absolute narrowing and speak of percent
reductions in cross-sectional area. This probably does not
offer any important advantage over the traditional measure-
ment of percent diameter stenosis.
Remodeling of the sclerotic arterial wall. A final consid-
eration in attempts to quantify arteriographic lesions is that
atherosclerosis involves a complex remodeling of the entire
arterial wall. Many of us have thought about coronary
lesions solely in terms of atherosclerotic proliferation, im-
plicitly expecting a one to one correlation between amount
of atherosclerotic material and reduction in luminal size. It is
now clear, however, that the atherosclerotic process pro-
ceeds in an outward as well as inward direction, and involves
an increase in external arterial diameter as well as a reduc-
tion in luminal diameter.
Figure 5 further illustrates the remodeling process. This
figure has been prepared with use of data from a recent study
by Stief et al. (3) in Hamburg of human coronary arteries
fixed at a normal arterial pressure. The proximal portion of a
normal artery is shown on the left and a stenotic atheroscle-
rotic artery on the right. The internal elastic membrane lies
at the base of the intima. If we compare the two arteries at
point A, we see that the atherosclerotic process does en-
croach on luminal area, but that the degree of encroachment
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Figure 6. The concept of flow reserve (see text).
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are widely patent and, as shown by the stylized vascular
smooth muscle (right), there is a high degree of vascular tone
at the arteriolar level in the microcirculation. If this tone is
abolished, for example, by dilating the peripheral coronary
bed with papaverine or dipyridamole, coronary flow can
increase fivefold (large triangle and maximally dilated arte-
riole). Coronary flow reserve is defined as the ratio of flow
during maximal vasodilation to flow under initial conditions
at rest. The dashed line (Fig. 6) represents the relation
between flow and pressure during maximal vasodilation over
a wide range of pressures. The absolute value of flow reserve
will vary if vasodilation is accompanied by a change in
arterial pressure. For example, if dipyridamole were used as
the dilating agent, a small decrease in arterial pressure would
not be surprising and the value of flow reserve measured
might be closer to 4 than to 5.
Coronary flow reserve in coronary stenosis. Figure 7 indi-
cates how coronary vasodilator reserve compensates for
effects of epicardial coronary stenoses under conditions at
rest. Coronary flow is again plotted against coronary artery
pressure. As in Figure 6, flow at rest is designated as 1.0 and
the normal coronary pressure-flow point is shown by a large
circle. The horizontal distances between the normal operat-
ing point and the various degrees of stenosis (smaller circles)
reflect the pressure gradients across the stenoses under
conditions at rest. As shown by the diagrams above the
graph, progressive arteriolar vasodilation allows flow to be
maintained until stenosis diameter is narrowed by more than
90%. Because a portion of arteriolar vasodilator reserve is
used to maintain flow at the normal level, less reserve
remains when vasodilation is induced.
Figure 8 illustrates more clearly why measurements of
flow reserve seem so attractive for defining the functional
significance of a stenosis independent of arteriography.
Flows at rest and after vasodilation for individual lesions are
connected by the thin dashed lines, which are curvilinear
from reported studies of large patient groups, particularly
because arteriography is almost always accompanied by left
ventriculography and left ventricular function is recognized as
the single most powerful predictor of survival in risk stratifica-
tion. Finally, the test of time is in many ways the ultimate test
for any new technology and arteriography has certainly passed
this test successfully during the past 2 decades.
There remain important cognitive issues in the interpre-
tation of any arteriogram. The point at which arteriography
is performed in what is clearly a long-term disease is usually
determined by a clinical event, and the arteriographic snap-
shot often includes the effect of nitroglycerin administered
routinely as filming is begun. The functional implications of
a stenosis always require careful clinical correlation. Func-
tional severity varies with both coronary flow and small
changes in degree of stenosis. Dynamic changes in degree of
stenosis are frequent and involve both thrombus formation
and effects of a variety of vasoactive substances. All ap-
proaches for quantifying the degree of stenosis have substan-
tiallimitations and some of us feel that these are unlikely to
be surmounted by new radiographic approaches. Complex
issues also arise in extrapolating information derived from
studies in patients with stable angina to those with acute
ischemic syndromes. Patients with acute syndromes form a
substantially larger proportion of individuals undergoing
arteriography now than they did only a few years ago, and
many arteriographers believe that the surface configurations
of lesions differ systematically in acute and chronic situa-
tions. Although we often have no better option than to
extrapolate from findings in patients with stable angina
studied in the late 1970s and early 1980s, there are special
challenges in doing so. Arteriography seems particularly
limited with respect to management decisions that involve a
judgment about the short-term likelihood ofa new thrombus.
Studies of Myocardial Perfusion
In view of the material just presented, there remain-even
in 1990-many shades of gray to be distinguished in the use of
arteriographic information in individual patient care decisions.
Studies of myocardial perfusion are intended to assist in such
decisions by defining the functional end result of whatever
arteriographic abnormalities are present. The variety of ap-
proaches to perfusion imaging included in the scientific pro-
gram at this College meeting attests to the importance and still
evolving nature of perfusion technology. Although time does
not permit a detailed discussion of strengths and limitations of
individual techniques, I would like to address interpretive
issues that are common to most techniques by considering
them in the context of coronary flow reserve.
The coronary flow reserve concept. In Figure 6 coronary
flow is plotted against coronary artery pressure. In the
normal situation under conditions at rest (large circle), with
flow designated as 1.0 (left), the epicardial coronary arteries
lACC Vol. 16. No.4
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Figure 7. Use of coronary vasodilator reserve to compensate for
effects of coronary stenoses under basal conditions. Progressive
arteriolar vasodilation (top diagrams) allows coronary flow to be
maintained until stenosis diameter is narrowed to >90% (circles on
graph) (see text).
CORONARY PRESSURE
Figure 9. Hypertrophy-induced shift in the pressure-flow relation
during maximal vasodilation. Directionally similar shifts can also be
caused by myocardial scarring. tachycardia. increased ventricular
preload and other factors (see text). LVH = left ventricular hyper-
trophy.
Figure 8. Use of coronary flow reserve to evaluate the functional
significance of stenotic lesions. Coronary flows at rest and after
vasodilation for individual stenotic lesions are connected by curvi-
linear dashed lines (see text). Cor. A. = coronary artery.
because of the effects of flow separation mentioned earlier.
The amount of flow that can be achieved during maximal
vasodilation varies inversely with the degree of stenosis. On
first glance, it would appear that stenoses in the clinically
difficult range between 50% and 90% should be readily
separated by a numeric measurement of flow reserve. With
use of the Doppler technology developed by the late Melvin
Marcus (4), who is missed at this meeting by all of us. it is
now possible to obtain numeric measurements of flow re-
serve in individual coronary arteries. In anyone patient,
however, the numeric value of flow reserve varies not only
with changes in arterial pressure, as noted earlier, but also
with changes in other hemodynamic variables such as heart
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rate and ventricular preload. Additional confounding factors
in coronary disease are myocardial scarring and ventricular
hypertrophy. Growth of vascular channels does not always
keep pace with hypertrophy of muscular elements, leading to
the situation shown in Figure 9.
Role of ventricular hypertrophy. Figure 9 points out that
the position of the pressure-flow relation during maximal
vasodilation changes substantially with ventricular hypertro-
phy. The magnitude of the shift shown is that expected for a
30% increase in left ventricular mass. as derived from
measurements in hypertensive patients by Strauer (5). The
numeric value of flow reserve in Figure 9 is essentially
identical for a 70% stenosis in a normal ventricle and a 50%
stenosis in the hypertrophied ventricle. A number of patho-
logic studies (6) suggest that hypertrophy of this degree is the
rule rather than the exception in coronary disease and has
already developed in individuals whose initial manifestation
of coronary disease is sudden death .
Clinical implications of flow reserve measurements. Be-
fore concluding our discussion of numeric values of flow
reserve, we should note an important difference in the use of
these measurements by the practicing cardiologist as com-
pared with the clinical investigator. The Iowa group (7) has
collected Doppler velocity probe data that nicely define the
reciprocal pathophysiologic relation between flow reserve
and degree of stenosis in humans. In establishing this rela-
tion, the investigators chose, quite understandably, to in-
clude only patients with a discrete single stenosis rather than
arteriographically diffuse disease and to exclude patients
with myocardial hypertrophy, left ventricular dysfunction,
previous myocardial infarction or angiographically apparent
collateral circulation. as each of these factors might have
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Figure 10. Examples 000% reductions in regional myocardial flow,
which have different clinical implications. Left, Exercise with angina
at a low work load. Center, Exercise with angina at a high work
load. Right, Vasodilation with dipyridamole.
Extrapolating from the studies of Kitamura et al. (8) in
Minnesota in the early 1970s, the flow of 1.6 times control in
the nonstenotic area (Fig. 10, left) would correspond to an
exercise level of 3 metabolic exercise equivalents (METs),
whereas the flow of 3.4 times control (center) would corre-
spond to an exercise level of 10 METs. Although the relative
perfusion deficits are similar in these two illustrations, the
therapeutic implications of ischemia at 3 and 10 METs
clearly differ. During maximal vasodilation after dipyrida-
mole (Fig. 10, right), flows in portions of the ventricle
supplied by nonstenotic vessels should be substantially
higher than during exercise and are shown here as reaching
five times initial values. A 30% reduction in flow in this
situation corresponds to an absolute level of flow that is 3.5
times the initial value and is not accompanied by an increase
in myocardial oxygen demand. Here, then, is a perfusion
deficit not associated with ischemia. Although it may be
diagnostically useful in identifying the presence ofan asymp-
tomatic stenotic lesion, it would ordinarily have little thera-
peutic impact.
One additional comment about perfusion imaging during
pharmacologic vasodilation. Figure 10 suggests that this
approach might be more sensitive than exercise imaging for
identifying stenoses of modest severity, that is, for diagnos-
tic screening. For this actually to be the case, however, the
imaging technique would have to be able to distinguish
between two high levels of flow, in this case, 3.5 and 5 times
values at rest. Data illustrating that such distinctions are not
always possible are provided in a recent study of technetium
isonitrile by Glover and Okada (9). When myocardial uptake
of technetium was plotted against coronary flow in dogs
given dipyridamole, myocardial technetium concentration
reached a plateau at a flow of 2.0 ml/min per g, that is, about
2.5 times flow at rest, and did not change with further
increases in flow. A defect such as that shown in Figure 10
(right) would apparently not be visualized with technetium
isonitrile as a tracer for dipyridamole imaging.
One final point about perfusion imaging during vasodila-
tion. Although time has not permitted discussion of trans-
mural variations in perfusion, we all recognize that flow
limitations usually begin in the subendocardium, and are
more marked in the subendocardium when flow is reduced
across the entire myocardial wall. Data to be presented later
in this meeting by Canty et al. (10) from our group illustrate
the point. When coronary flow was reduced in sequential
steps in chronically instrumented dogs during pharmacologic
vasodilation, the degree of flow reduction was always
greater in the subendocardium than in the full thickness
myocardium. Thus, as perfusion scan technology continues
to evolve, techniques that have sufficient resolution to assess
subendocardial flow selectively may be especially advanta-
geous.
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influenced flow reserve independent of the stenotic lesion. A
clinician dealing with an individual patient must keep in mind
not only these exclusions but also the 95% confidence limits
for any individual value of flow reserve. These limits were
quite wide in the Iowa study, varying for example from 1.2 to
4.2 in cases of70% diameter stenosis and from - 3.8 to -8.2
in individuals without coronary disease.
Interpretation of myocardial perfusion images. Let us
next consider coronary flow reserve in relation to perfusion
images. Because a clinician is usually trying to identify a
regional abnormality in perfusion, techniques that allow
comparison of different regions of a ventricle can avoid some
of the pitfalls of numeric measurements of flow reserve.
When we combine perfusion imaging with a stress test or
dipyridamole infusion, we are really trying to determine
whether flow reserve is reduced on a regional basis, and we
focus on the presence or absence of a regional difference
rather than on absolute values. The minimal size of an image
defect that can be appreciated is limited by the resolution of
each technique and also varies with the physical character-
istics of the individual patient. Although there are few data
directly addressing the minimal difference in regional flow
needed for a defect to be appreciated, a difference of at least
30% is probably needed for most techniques under condi-
tions at rest. In addition, because the myocardial extraction
of some commonly used tracers varies inversely with flow,
the relative flow difference needed to identify a defect during
vasodilation is often greater than at rest.
Figure 10 raises additional interpretive issues by illustrat-
ing three situations that might be expected to produce similar
defects on perfusion images but that would have significantly
different clinical implications, namely, exercise with angina
at a low work load, exercise with angina at a high work load
and pharmacologic vasodilation. In each case, flow in a
portion of the ventricle supplied by a stenosed coronary
artery is 30% less than flow in the remainder of the ventricle.
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Figure 11. "Shades of gray" in each of the major factors influencing
patient care decisions in coronary disease. LV = left ventricular.
Conclusions: Shades of Gray
In view of the points just discussed, it is fair to say that
there are important shades of gray to be discerned in the
clinical use of perfusion studies as well as arteriography (Fig.
11). As specific technologies and tracers continue to evolve.
it may be helpful to recall what has been termed the "lesson
of ejection fraction." When it first became practical to
measure ejection fraction clinically, a number of hemody-
namic, technical and other potentially confounding factors
were identified rather quickly. As we all realize, however,
the test of time proved these problems to be either satisfac-
torily surmounted or clinically unimportant. As we now
continue to sort out the relative strengths and weaknesses of
newer perfusion technologies, the test of time will no doubt
again play an important role in defining the ultimate status of
each technology in routine clinical care.
Although I have discussed only one aspect of the clinical
profile, several other, at least equally important components
must be mentioned. The presence or absence of angina or
electrocardiographic abnormalities at rest, or both, and
findings on routine stress testing clearly allow patients with
coronary disease to be placed in highly relevant clinical
subsets. Decisions concerning revascularization often de-
pend on the results of a trial of medical therapy. Risk factor
profiles and probabilities of risk factor modification can also
influence individual judgments. In some circumstances silent
ischemia may be an additional modifying factor. And even
when all these issues have been factored into an individual
case, another set of considerations arises if the clinician
notes a carotid bruit or an enlarged pulsatile aorta, or if
patient preferences do not readily coincide with what we
consider to be "best medical judgment." Indeed, many
would persuasively argue that the spectrum of shades ofgray
in the clinical profile is even broader than in arteriography or
assessments of left ventricular function.
In the last analysis, then. cognition remains the core of
cardiovascular medicine even in this era of the technology
explosion (Fig. 12). We are still physicians rather than
proceduralists and healers rather than fixers. The truly
Figure 12. Cognitive synthesis of "shades of gray" in individual
patient care decisions. Abbreviation as in Figure II.
challenging task as we enter the 1990s is to discern among
the almost infinite number of shades of gray that we can now
identify clinically and technologically and to reconcile them
into a cohesive whole for each of the patients we serve. Our
opportunity to do so is unparalleled and our responsibility to
do so seems equally clear.
I am indebted to C. Richard Conti. MD. our 1989-90 ACC President. for his
invitation to deliver this year's Opening Plenary Session Lecture. I also
express my appreciation to the many past and present colleagues who have
shaped my thinking about the matters discussed.
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